nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—Gefitinib—EGFR—melanoma	0.00532	0.616	CrCbGaD
Minaprine—Gefitinib—ALB—melanoma	0.00169	0.196	CrCbGaD
Minaprine—Gefitinib—ABCB1—melanoma	0.00162	0.187	CrCbGaD
Minaprine—CHRM1—Signaling Pathways—FN1—melanoma	6.5e-05	6.55e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NOTCH1—melanoma	6.5e-05	6.55e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PIK3CB—melanoma	6.45e-05	6.5e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CDKN1B—melanoma	6.42e-05	6.47e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NOTCH1—melanoma	6.39e-05	6.45e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MAP2K1—melanoma	6.37e-05	6.43e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CD80—melanoma	6.36e-05	6.42e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NOTCH1—melanoma	6.36e-05	6.41e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CG—melanoma	6.35e-05	6.41e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—APC—melanoma	6.35e-05	6.41e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—KIT—melanoma	6.35e-05	6.41e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—NRAS—melanoma	6.35e-05	6.41e-05	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—AKT1—melanoma	6.35e-05	6.4e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PIK3CD—melanoma	6.33e-05	6.38e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CASP3—melanoma	6.29e-05	6.34e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—EGF—melanoma	6.28e-05	6.33e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IL2—melanoma	6.28e-05	6.33e-05	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—PIK3CA—melanoma	6.27e-05	6.32e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CD80—melanoma	6.26e-05	6.32e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—APC—melanoma	6.25e-05	6.3e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—KIT—melanoma	6.25e-05	6.3e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CG—melanoma	6.25e-05	6.3e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—NRAS—melanoma	6.25e-05	6.3e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—IL6—melanoma	6.25e-05	6.3e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CD80—melanoma	6.23e-05	6.28e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CG—melanoma	6.22e-05	6.27e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—KIT—melanoma	6.22e-05	6.27e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—APC—melanoma	6.22e-05	6.27e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—NRAS—melanoma	6.22e-05	6.27e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CXCL8—melanoma	6.2e-05	6.25e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—KRAS—melanoma	6.2e-05	6.25e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—EGF—melanoma	6.18e-05	6.23e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—HRAS—melanoma	6.16e-05	6.21e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ABCB1—melanoma	6.15e-05	6.2e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—EGF—melanoma	6.15e-05	6.2e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CCND1—melanoma	6.12e-05	6.17e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—MAPK3—melanoma	6.08e-05	6.14e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CTNNB1—melanoma	6.06e-05	6.11e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—FGF2—melanoma	6.06e-05	6.11e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CDKN1B—melanoma	6.05e-05	6.1e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—MAPK3—melanoma	5.99e-05	6.04e-05	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—AKT1—melanoma	5.98e-05	6.04e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—BRAF—melanoma	5.97e-05	6.02e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—MAPK3—melanoma	5.95e-05	6.01e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MMP9—melanoma	5.94e-05	5.99e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CASP3—melanoma	5.93e-05	5.98e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IL2—melanoma	5.92e-05	5.97e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CDKN1A—melanoma	5.92e-05	5.97e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PTEN—melanoma	5.91e-05	5.96e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—IL6—melanoma	5.89e-05	5.94e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—NFKB1—melanoma	5.88e-05	5.93e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—BRAF—melanoma	5.88e-05	5.93e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—BRAF—melanoma	5.84e-05	5.89e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IGF1—melanoma	5.82e-05	5.87e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—MAPK1—melanoma	5.79e-05	5.84e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—EGFR—melanoma	5.79e-05	5.84e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CCND1—melanoma	5.77e-05	5.82e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—AKT1—melanoma	5.76e-05	5.81e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IGF1—melanoma	5.72e-05	5.77e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CTNNB1—melanoma	5.72e-05	5.77e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—MAPK1—melanoma	5.7e-05	5.75e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—EGFR—melanoma	5.69e-05	5.74e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IGF1—melanoma	5.69e-05	5.74e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—PIK3CA—melanoma	5.69e-05	5.74e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MDM2—melanoma	5.67e-05	5.72e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—MAPK1—melanoma	5.67e-05	5.71e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—EGFR—melanoma	5.66e-05	5.71e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PRKCA—melanoma	5.66e-05	5.71e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MAP2K1—melanoma	5.62e-05	5.67e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ERCC2—melanoma	5.61e-05	5.66e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MMP9—melanoma	5.6e-05	5.65e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ERBB2—melanoma	5.59e-05	5.64e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CD—melanoma	5.58e-05	5.63e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CDKN1A—melanoma	5.58e-05	5.63e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PTEN—melanoma	5.57e-05	5.62e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NFKB1—melanoma	5.54e-05	5.59e-05	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—PIK3CA—melanoma	5.53e-05	5.58e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MAP2K1—melanoma	5.53e-05	5.58e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PIK3CB—melanoma	5.52e-05	5.56e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MAP2K1—melanoma	5.5e-05	5.55e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CD—melanoma	5.49e-05	5.54e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—KRAS—melanoma	5.47e-05	5.52e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CD—melanoma	5.47e-05	5.51e-05	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—PIK3CA—melanoma	5.44e-05	5.49e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—AKT1—melanoma	5.43e-05	5.48e-05	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—PIK3CA—melanoma	5.41e-05	5.46e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—KRAS—melanoma	5.38e-05	5.43e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—KRAS—melanoma	5.35e-05	5.4e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—FGF2—melanoma	5.35e-05	5.39e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—VEGFA—melanoma	5.34e-05	5.38e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CXCL8—melanoma	5.3e-05	5.35e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—STAT3—melanoma	5.28e-05	5.33e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—NRAS—melanoma	5.27e-05	5.32e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—HRAS—melanoma	5.27e-05	5.31e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—FGF2—melanoma	5.26e-05	5.31e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—FGF2—melanoma	5.23e-05	5.28e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CDKN1B—melanoma	5.18e-05	5.22e-05	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—AKT1—melanoma	5.12e-05	5.16e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CASP3—melanoma	5.07e-05	5.12e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IL2—melanoma	5.07e-05	5.11e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MAPK3—melanoma	5.05e-05	5.09e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PIK3CA—melanoma	5.05e-05	5.09e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—IL6—melanoma	5.04e-05	5.08e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—VEGFA—melanoma	5.03e-05	5.08e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—PIK3CA—melanoma	5.02e-05	5.07e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MDM2—melanoma	5e-05	5.05e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—STAT3—melanoma	4.98e-05	5.03e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NRAS—melanoma	4.97e-05	5.01e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—PIK3CA—melanoma	4.94e-05	4.99e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CCND1—melanoma	4.94e-05	4.98e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ERBB2—melanoma	4.93e-05	4.98e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MDM2—melanoma	4.92e-05	4.97e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—PIK3CA—melanoma	4.92e-05	4.96e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MYC—melanoma	4.91e-05	4.95e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MDM2—melanoma	4.9e-05	4.94e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CTNNB1—melanoma	4.89e-05	4.93e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CB—melanoma	4.87e-05	4.91e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ERBB2—melanoma	4.85e-05	4.9e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ERBB2—melanoma	4.83e-05	4.87e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MAPK1—melanoma	4.8e-05	4.84e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—EGFR—melanoma	4.8e-05	4.84e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MMP9—melanoma	4.79e-05	4.84e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CB—melanoma	4.79e-05	4.83e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CDKN1A—melanoma	4.78e-05	4.82e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PTEN—melanoma	4.77e-05	4.81e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CB—melanoma	4.76e-05	4.81e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MAPK3—melanoma	4.76e-05	4.8e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PIK3CA—melanoma	4.75e-05	4.8e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NFKB1—melanoma	4.74e-05	4.78e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CXCL8—melanoma	4.68e-05	4.72e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—AKT1—melanoma	4.65e-05	4.69e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—HRAS—melanoma	4.65e-05	4.69e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MYC—melanoma	4.63e-05	4.67e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CXCL8—melanoma	4.6e-05	4.64e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CXCL8—melanoma	4.58e-05	4.62e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—HRAS—melanoma	4.57e-05	4.61e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CDKN1B—melanoma	4.57e-05	4.61e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—HRAS—melanoma	4.55e-05	4.59e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—KRAS—melanoma	4.54e-05	4.58e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MAPK1—melanoma	4.53e-05	4.57e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—EGFR—melanoma	4.53e-05	4.57e-05	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—AKT1—melanoma	4.52e-05	4.56e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CDKN1B—melanoma	4.49e-05	4.53e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CASP3—melanoma	4.48e-05	4.52e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CDKN1B—melanoma	4.47e-05	4.51e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IL2—melanoma	4.47e-05	4.51e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—IL6—melanoma	4.45e-05	4.49e-05	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—AKT1—melanoma	4.45e-05	4.48e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CG—melanoma	4.43e-05	4.47e-05	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—AKT1—melanoma	4.42e-05	4.46e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CASP3—melanoma	4.41e-05	4.44e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IL2—melanoma	4.4e-05	4.44e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CASP3—melanoma	4.38e-05	4.42e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—IL6—melanoma	4.38e-05	4.41e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IL2—melanoma	4.38e-05	4.41e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CCND1—melanoma	4.36e-05	4.4e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—IL6—melanoma	4.35e-05	4.39e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CTNNB1—melanoma	4.32e-05	4.35e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—VEGFA—melanoma	4.3e-05	4.34e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CCND1—melanoma	4.29e-05	4.33e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—KRAS—melanoma	4.28e-05	4.32e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PPARG—melanoma	4.28e-05	4.31e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CCND1—melanoma	4.26e-05	4.3e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—STAT3—melanoma	4.26e-05	4.3e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NRAS—melanoma	4.25e-05	4.29e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CTNNB1—melanoma	4.25e-05	4.28e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MMP9—melanoma	4.23e-05	4.27e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CTNNB1—melanoma	4.22e-05	4.26e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CDKN1A—melanoma	4.22e-05	4.25e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PTEN—melanoma	4.21e-05	4.24e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NFKB1—melanoma	4.19e-05	4.22e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PIK3CA—melanoma	4.17e-05	4.2e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MMP9—melanoma	4.16e-05	4.2e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CDKN1A—melanoma	4.15e-05	4.18e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MMP9—melanoma	4.14e-05	4.18e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PTEN—melanoma	4.14e-05	4.17e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CDKN1A—melanoma	4.13e-05	4.16e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—AKT1—melanoma	4.12e-05	4.16e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NFKB1—melanoma	4.12e-05	4.15e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PTEN—melanoma	4.12e-05	4.15e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—AKT1—melanoma	4.1e-05	4.14e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NFKB1—melanoma	4.1e-05	4.13e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MAPK3—melanoma	4.07e-05	4.11e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—AKT1—melanoma	4.04e-05	4.07e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TP53—melanoma	4.03e-05	4.07e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—AKT1—melanoma	4.02e-05	4.05e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MYC—melanoma	3.96e-05	4e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PIK3CA—melanoma	3.93e-05	3.96e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CD—melanoma	3.9e-05	3.93e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—AKT1—melanoma	3.88e-05	3.92e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MAPK1—melanoma	3.87e-05	3.91e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—EGFR—melanoma	3.87e-05	3.91e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—HRAS—melanoma	3.86e-05	3.89e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ALB—melanoma	3.85e-05	3.88e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TP53—melanoma	3.8e-05	3.84e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—VEGFA—melanoma	3.8e-05	3.83e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—STAT3—melanoma	3.76e-05	3.79e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NRAS—melanoma	3.75e-05	3.79e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—VEGFA—melanoma	3.74e-05	3.77e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—VEGFA—melanoma	3.72e-05	3.75e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—STAT3—melanoma	3.7e-05	3.73e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NRAS—melanoma	3.69e-05	3.72e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IL6—melanoma	3.69e-05	3.72e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—STAT3—melanoma	3.68e-05	3.71e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NRAS—melanoma	3.67e-05	3.7e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—KRAS—melanoma	3.66e-05	3.69e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—HRAS—melanoma	3.64e-05	3.67e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MAPK3—melanoma	3.59e-05	3.63e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MAPK3—melanoma	3.54e-05	3.57e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MAPK3—melanoma	3.52e-05	3.55e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MYC—melanoma	3.5e-05	3.53e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IL6—melanoma	3.48e-05	3.51e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MYC—melanoma	3.44e-05	3.47e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MYC—melanoma	3.42e-05	3.45e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MAPK1—melanoma	3.42e-05	3.45e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—EGFR—melanoma	3.42e-05	3.45e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—AKT1—melanoma	3.4e-05	3.43e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CB—melanoma	3.4e-05	3.43e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MAPK1—melanoma	3.36e-05	3.39e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PTGS2—melanoma	3.36e-05	3.39e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—EGFR—melanoma	3.36e-05	3.39e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PIK3CA—melanoma	3.36e-05	3.39e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MAPK1—melanoma	3.35e-05	3.38e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—EGFR—melanoma	3.35e-05	3.38e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TP53—melanoma	3.25e-05	3.28e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—KRAS—melanoma	3.23e-05	3.26e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—AKT1—melanoma	3.21e-05	3.24e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—KRAS—melanoma	3.18e-05	3.21e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—KRAS—melanoma	3.16e-05	3.19e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HRAS—melanoma	3.11e-05	3.14e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IL6—melanoma	2.98e-05	3e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CA—melanoma	2.97e-05	2.99e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PTEN—melanoma	2.93e-05	2.96e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CA—melanoma	2.92e-05	2.95e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CA—melanoma	2.9e-05	2.93e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TP53—melanoma	2.87e-05	2.9e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TP53—melanoma	2.82e-05	2.85e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TP53—melanoma	2.81e-05	2.83e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—AKT1—melanoma	2.75e-05	2.77e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HRAS—melanoma	2.75e-05	2.77e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—HRAS—melanoma	2.7e-05	2.72e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HRAS—melanoma	2.69e-05	2.71e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IL6—melanoma	2.63e-05	2.65e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IL6—melanoma	2.59e-05	2.61e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IL6—melanoma	2.57e-05	2.59e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AKT1—melanoma	2.42e-05	2.45e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AKT1—melanoma	2.39e-05	2.41e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AKT1—melanoma	2.37e-05	2.39e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CA—melanoma	2.07e-05	2.09e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—AKT1—melanoma	1.69e-05	1.71e-05	CbGpPWpGaD
